Jason Wilk, the CEO of digital banking service Dave, remembers the absolute low point in his brief career as head of a publicly-traded firm.
It was June 2023, and shares of his company had recently dipped below $5 apiece. Desperate to keep Dave afloat, Wilk found himself at a Los Angeles conference for micro-cap stocks, where he pitched investors on tiny $5,000 stakes in his firm.
“I’m not going to lie, this was probably the hardest time of my life,” Wilk told CNBC. “To go from being a $5 billion company to $50 million in 12 months, it was so freaking hard.”
But in the months that followed, Dave turned profitable and consistently topped Wall Street analyst expectations for revenue and profit. Now, Wilk’s company is the top gainer for 2024 among U.S. financial stocks, with a 934% year-to-date surge through Thursday.
The fintech firm, which makes money by extending small loans to cash-strapped Americans, is emblematic of a larger shift that’s still in its early stages, according to JMP Securities analyst Devin Ryan.
Investors had dumped high-flying fintech companies in 2022 as a wave of unprofitable firms like Dave went public via special purpose acquisition companies. The environment turned suddenly, from rewarding growth at any cost to deep skepticism of how money-losing firms would navigate rising interest rates as the Federal Reserve battled inflation.
Now, with the Fed easing rates, investors have rushed back into financial firms of all sizes, including alternative asset managers like KKR and credit card companies like American Express, the top performers among financial stocks this year with market caps of at least $100 billion and $200 billion, respectively.
Big investment banks including Goldman Sachs, the top gainer among the six largest U.S. banks, have also surged this year on hope for a rebound in Wall Street deals activity.
Dave, a fintech firm taking on big banks like JPMorgan Chase, is a standout stock this year.
But it’s fintech firms like Dave and Robinhood, the commission-free trading app, that are the most promising heading into next year, Ryan said.
Robinhood, whose shares have surged 190% this year, is the top gainer among financial firms with a market cap of at least $10 billion.
“Both Dave and Robinhood went from losing money to being incredibly profitable firms,” Ryan said. “They’ve gotten their house in order by growing their revenues at an accelerating rate while managing expenses at the same time.”
While Ryan views valuations for investment banks and alternative asset manages as approaching “stretched” levels, he said that “fintechs still have a long way to run; they are early in their journey.”
Financials broadly had already begun benefitting from the Fed easing cycle when the election victory of Donald Trump last month intensified interest in the sector. Investors expect Trump will ease regulation and allow for more innovation with government appointments including ex-PayPal executive and Silicon Valley investor David Sacks as AI and crypto czar.
Those expectations have boosted the shares of entrenched players like JPMorgan Chase and Citigroup, but have had a greater impact on potential disruptors like Dave that could see even more upside from a looser regulatory environment.
Gas & groceries
Dave has built a niche among Americans underserved by traditional banks by offering fee-free checking and savings accounts.
It makes money mostly by extending small loans of around $180 each to help users “pay for gas and groceries” until their next paycheck, according to Wilk; Dave makes roughly $9 per loan on average.
Customers come out ahead by avoiding more expensive forms of credit from other institutions, including $35 overdraft fees charged by banks, he said. Dave, which is not a bank, but partners with one, does not charge late fees or interest on cash advances.
The company also offers a debit card, and interchange fees from transactions made by Dave customers will make up an increasing share of revenue, Wilk said.
While the fintech firm faces far less skepticism now than it did in mid-2023— of the seven analysts who track it, all rate the stock a “buy,” according to Factset — Wilk said the company still has more to prove.
“Our business is so much better now than we went public, but it’s still priced 60% below the IPO price,” he said. “Hopefully we can claw our way back.”
UnitedHealth Group saw some of its insiders step in and purchase declining shares this week.
Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday.
Shares of UnitedHealth plunged nearly 11% to $274.35 on Thursday following a report in The Wall Street Journal that the Department of Justice is conducting a criminal investigation into possible Medicare fraud.
UnitedHealth Group , whose stock has been in a tailspin amid a tumultuous period for the health-care giant, saw some of its insiders step in and purchase declining shares this week. Kristen Gil, a director at the firm, bought 3,700 shares worth roughly $1 million on Thursday, while Timothy Patrick Flynn and John Noseworthy, also directors, scooped up about 1,500 and 300 shares , respectively, on Wednesday, according to InsiderScore, which tracks regulatory filings from corporate insiders. Shares of UnitedHealth plunged nearly 11% to $274.35 on Thursday following a report in The Wall Street Journal that the Department of Justice is conducting a criminal investigation into possible Medicare fraud. The stock rebounded 6% Friday, cutting its weekly losses to 23%. UNH 5D mountain UnitedHealth The reported investigation also follows the surprise exit of UnitedHealth Group CEO Andrew Witty, who will be replaced by the company’s former longtime chief executive Stephen Hemsley. Shares of UnitedHealth Group are down roughly 43% this year following a string of setbacks for the company. The company has been grappling with a historic cyberattack, higher-than-expected medical costs and a torrent of public blowback after the murder of UnitedHealthcare CEO Brian Thompson.
U.S. Federal Reserve in Washington, DC, on January 30, 2024.
Mandel Ngan | Afp | Getty Images
The Federal Reserve will look to reduce its headcount by 10% over the next couple of years, including offering deferred resignation to some older employees, central bank chair Jerome Powell said in a memo.
“Experience here and elsewhere shows that it is healthy for any organization to periodically take a fresh look at its staffing and resources. The Fed has done that from time to time as our work, priorities, or external environment have changed,” Powell said in a memo obtained by CNBC.
The central bank chief added that he has instructed leaders throughout the Fed “to find incremental ways to consolidate functions where appropriate, modernize some business practices, and ensure that we are right-sized and able to meet our statutory mission.” One method for shrinking the staff will be to offer a voluntary deferred resignation program to employees of the Federal Reserve Board who would be fully eligible to retire at the end of 2027.
The central bank said in its 2023 annual report that it had just under 24,000 employees. A 10% reduction would bring that number below 22,000.
The memo comes as the Trump administration has pushed for cost cuts across civil service agencies, spearheaded by Elon Musk and the so-called Department of Government Efficiency. Musk has previously called the Fed “absurdly overstaffed.” Powell’s memo did not mention Musk or DOGE as a factor in the decision to shrink headcount.
The planned staff cuts were first reported by Bloomberg News.
Check out the companies making headlines in midday trading. Applied Materials — Shares of the semiconductor manufacturer dropped 6% after Applied Materials posted disappointing fiscal second-quarter revenue. The company’s revenue of $7.10 billion was below the LSEG consensus of $7.13 billion. Semiconductor revenue of $5.26 billion also disappointed the $5.31 billion analysts were looking for. Take-Two Interactive Software — The stock slid 1.8% after the video game company gave weaker-than-anticipated guidance for full-year bookings, expecting the figure to come between $5.9 billion and $6 billion. That missed the $7.82 billion StreetAccount consensus. Take-Two also projected bookings of between $1.25 billion and $1.30 billion for the current quarter, while analysts had penciled in $1.28 billion. Vistra — Shares of the power producer gained 3% after the company purchased seven natural gas facilities from Lotus Infrastructure Partners for $1.9 billion. The gas plants are located in the PJM market, New England, New York and California. Constellation Brands — Shares of the Corona and Modelo importer climbed 1.4% after Berkshire Hathaway disclosed doubling its stake in the company, putting its position at around $2.2 billion in value. Galaxy Digital — The Mike Novogratz-led crypto firm began trading at the Nasdaq on Friday, opening at $23.50 per share in a direct listing. Galaxy Digital has traded in Canada since 2020 . Cava — The eatery chain’s stock dropped more than 2% after the company reiterated its full-year guidance for same restaurant sales, implying a slowdown from first-quarter results. Cava said it achieved 10.8% same store sales growth. However, it maintained a full-year projection of 6% to 8% improvement in that category. Cava’s earnings per share of 22 cents for the period was ahead of projections for 14 cents per share, according to LSEG. Fiserv — The financial services provider jumped more than 4% as the stock recovered some of its steep losses for the week. Fiserv is down more than 9% this week and is one of the most oversold names on Wall Street, with a relative strength index below 30. Coinbase — The crypto exchange jumped more than 9%, recovering losses from the previous session. Some Wall Street analysts called the sell-off overdone and a buying opportunity . On Thursday, the company confirmed the Securities and Exchange Commission has been investigating whether it has misstated its user numbers , sending the stock down 7.2%. Novo Nordisk — Shares stumbled 3% after the pharmaceutical company announced that CEO Lars Fruergaard Jørgensen would be stepping down from his position , citing recent market challenges. Jørgensen, who was in the position for the last eight years, will remain “for a period to support a smooth transition to new leadership” as Novo Nordisk searches for a successor. Doximity — The health care platform issued weak guidance, sending the stock down 11.8%. Doximity expects adjusted EBITDA for the first quarter to come in between $71 million and $72 million. That’s short of the $74 million expected from analysts polled by StreetAccount. Revenue guidance for both the first quarter and full year also missed expectations. — CNBC’s Tanaya Macheel, Lisa Han, Jesse Pound and Michelle Fox contributed reporting.